|
Barrachina MN, Izquierdo I, Hermida-Nogueira L, Moran LA, Perez A, Arroyo AB, Garcia-Barbera N, Gonzalez-Conejero R, Troitino S, Eble JA, Rivera J, Martinez C, Loza MI, Dominguez E, Garcia A. The PI3Kdelta Inhibitor Idelalisib Diminishes Platelet Function and Shows Antithrombotic Potential. Int J Mol Sci. 2021 Mar 24;22(7):3304. doi: 10.3390/ijms22073304. PubMed PMID: 33804911; PubMed Central PMCID: PMC8037016.
AÑO: 2021; IF: 6.208
|
33804911
|
Arroyo AB, Fernandez-Perez MP, Del Monte A, Aguila S, Mendez R, Hernandez-Antolin R, Garcia-Barber N, de Los Reyes-Garcia AM, Gonzalez-Jimenez P, Arcas MI, Vicente V, Menendez R, Andres V, Gonzalez-Conejero R, Martinez C. miR-146a is a pivotal regulator of neutrophil extracellular trap formation promoting thrombosis. Haematologica. 2021 Jun 1;106(6):1636-1646. doi: 10.3324/haematol.2019.240226. PubMed PMID: 32586906; PubMed Central PMCID: PMC8168495.
AÑO: 2021; IF: 11.047
|
|
Lozano ML, Garabet L, Fernandez-Perez MP, De Los Reyes-Garcia AM, Diaz-Lozano P, Garcia-Barbera N, Aguila S, Vicente V, Ghanima W, Martinez C, Gonzalez-Conejero R. Platelet activation and neutrophil extracellular trap (NET) formation in immune thrombocytopenia: is there an association? Platelets. 2020 Oct 2;31(7):906-912. doi: 10.1080/09537104.2019.1696456. Epub 2019 Nov 24. PubMed PMID: 31762368.
AÑO: 2020; IF: 3.862
|
|
Garabet L, Henriksson CE, Lozano ML, Ghanima W, Bussel J, Brodin E, Fernandez-Perez MP, Martinez C, Gonzalez-Conejero R, Mowinckel MC, Sandset PM. Markers of endothelial cell activation and neutrophil extracellular traps are elevated in immune thrombocytopenia but are not enhanced by thrombopoietin receptor agonists. Thromb Res. 2020 Jan;185:119-124. doi: 10.1016/j.thromres.2019.11.031. Epub 2019 Nov 30. PubMed PMID: 31805421.
AÑO: 2020; IF: 3.944
|
|
Ferrer-Marin F, Arroyo AB, Bellosillo B, Cuenca EJ, Zamora L, Hernandez-Rivas JM, Hernandez-Boluda JC, Fernandez-Rodriguez C, Luno E, Garcia Hernandez C, Kerguelen A, Fiallo-Suarez DV, Gomez-Casares MT, Ayala R, Velez P, Boque C, Garcia-Gutierrez V, Arrizabalaga B, Estrada N, Cifuentes R, Arcas I, de Los Reyes-Garcia AM, Besses C, Vicente V, Alvarez-Larran A, Teruel-Montoya R, Gonzalez-Conejero R, Martinez C; GEMFIN Group. miR-146a rs2431697 identifies myeloproliferative neoplasm patients with higher secondary myelofibrosis progression risk. Leukemia. 2020 Oct;34(10):2648-2659. doi: 10.1038/s41375-020-0767-3. Epub 2020 Feb 27. PubMed PMID: 32107471.
AÑO: 2020; IF: 12.883
|